Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why
Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why
Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country's Health Ministry which undertook expert hearings on various aspects of the issue with a focus on the best ways to protect young people and consumers' health.
德國正在慢慢走向娛樂性大麻合法化正如政府試圖在2022年底之前完成這一進程。最新的推動來自該國的衞生部就這一問題的各個方面舉行了專家聽證會重點是保護年輕人和消費者健康的最佳方式。
The move could be a major catalyst for the market, especially for cannabis companies such as Tilray Brands, Inc. (NASDAQ:TLRY), which has operations in Germany.
這一舉措可能成為市場的主要催化劑，特別是對大麻公司來説，如Tilray Brands公司(納斯達克：TLRY)，在德國有業務。
Cantor Fitzgerald's analyst Pablo Zuanic said in his recent note that the sentiment for the company's stock may improve going forward.
康託·菲茨傑拉德的分析師巴勃羅·祖阿尼克在他最近的筆記中説，對該公司股票的情緒可能會在未來有所改善。
"We expect sentiment for the stock to improve in the months ahead on the back of news flow from Germany on the legalization of recreational sales," Zuanic said.
祖阿尼克表示：“我們預計，在德國娛樂銷售合法化的消息傳出後，未來幾個月人們對該股的信心將有所改善。”
The Analyst
《分析師》
Zuanic retained a Neutral rating on the company's stock with a price target of $5.75, down from $6.15.
祖阿尼奇維持對該公司股票的中性評級，目標價從6.15美元降至5.75美元。
The Thesis
這篇論文是
The company is poised to benefit from being one of only three cannabis licensed manufacturers in Germany.
該公司是作為德國僅有的三家獲得許可的大麻製造商之一，該公司有望從中受益。
The Canadian cannabis giant finalized its first harvest of medical cannabis grown in Germany via its subsidiary Aphria RX GmbH in July 2021, several months following the merger with Aphria.
這家加拿大大麻巨頭通過其子公司完成了其在德國種植的第一批醫用大麻的收穫Aphria RX GmbH2021年7月，也就是與Aphria合併幾個月後。
The company is scheduled to report the fiscal fourth quarter at the end of July. Zuanic tweaked his sales estimates, lowering EBITDA assumptions and saying that Tilray has "become somewhat of a meme stock, in our opinion, with significant volatility to the heavy presence of retail investors."
該公司是計劃在7月底公佈第四財季。祖阿尼克微調了他的銷售預期，下調了EBITDA假設，並表示Tilray已經在我們看來，這在某種程度上成為了一種迷因股票，由於散户投資者的大量存在，股票的波動性很大。"
Strategic Partnership With HEXO
與HEXO建立戰略合作伙伴關係
In the meantime, it remains to be seen how the agreement with HEXO Corp. (NASDAQ:HEXO) will play out.
與此同時，還有待觀察的是，與HEXO公司達成協議(納斯達克：HEXO)都會發揮到最後。
Earlier this year, the Canadian cannabis giant entered into a strategic partnership with HEXO - a debt financing agreement - under which it agreed to acquire $211 million in senior secured convertible notes that HEXO originally issued to HT Investments MA LLC. In April, Tilray signed a definitive agreement to purchase 100% of the remaining US$193 million outstanding principal balance of the senior secured convertible note.
今年早些時候，加拿大大麻巨頭與HEXO達成戰略合作伙伴關係-債務融資協議-根據該協議，它同意收購HEXO最初向HT Investments MA LLC發行的2.11億美元優先擔保可轉換票據。今年4月，Tilray簽署了一項最終協議，將100%購買優先擔保可轉換票據剩餘的1.93億美元未償還本金餘額。
Last week, that deal was amended to address current stock market conditions and to reduce closing risk.
上個星期，那個對交易進行了修改，以應對當前的股市狀況並降低成交風險。
Zuanic said recently that Tilray could benefit from "HEXO's travails," leveraging the current state of the markets and the crisis HEXO is facing to negotiate terms, spend less cash and eventually convert the debt in a 50% equity stake in the company.
祖阿尼克最近表示，Tilray可能會從《HEXO的陣痛》中受益，利用目前的市場狀況和HEXO面臨的危機，HEXO就條款進行談判，減少現金支出，最終將債務轉換為公司50%的股權。
TLRY Price Action
TLRY價格行動
Tilray's shares traded 0.2123% higher at $3.5876 per share at the time of writing on Firday.
Tilray‘s股價上漲0.2123%，至每股3.5876美元。當我在星期五寫這篇文章的時候。
Benzinga photo. Source: Image from Shutterstock
本辛加的照片。圖片來源：Shutterstock
譯文內容由第三人軟體翻譯。